Abstract:DddA-derived cytosine base editors (DdCBEs) enable the targeted introduction of C·G-to-T·A conversions in mitochondrial DNA (mtDNA). DdCBEs are often deployed as pairs, with each arm comprised of a transcription activator-like effector (TALE), a split double-stranded DNA deaminase half, and a uracil glycosylase inhibitor. This pioneering technology has helped improve our understanding of cellular processes involving mtDNA and has paved the way for the development of models and therapies for genetic disorders caused by pathogenic mtDNA variants. Nonetheless, given the intrinsic properties of TALE proteins, several target sites in human mtDNA remain out of reach to DdCBEs and other TALE-based technologies. Specifically, due to the conventional requirement for a thymine immediately upstream of the TALE target sequences (i.e., the 5′-T constraint), over 150 loci in the human mitochondrial genome are presumed to be inaccessible to DdCBEs. Previous attempts at circumventing this constraint, either by developing monomeric DdCBEs or utilizing DNA-binding domains alternative to TALEs, have resulted in suboptimal specificity profiles with reduced therapeutic potential. Here, aiming to challenge and elucidate the relevance of the 5′-T constraint in the context of DdCBE-mediated mtDNA editing, and to expand the range of motifs that are editable by this technology, we generated αDdCBEs that contain modified TALE proteins engineered to recognize all 5′ bases. Notably, 5′-T-noncompliant, canonical DdCBEs efficiently edited mtDNA at diverse loci. However, DdCBEs were frequently outperformed by αDdCBEs, which consistently displayed significant improvements in activity and specificity, regardless of the 5′-most bases of their TALE binding sites. Furthermore, we showed that αDdCBEs are compatible with DddAtox and its derivatives DddA6, and DddA11, and we validated TALE shifting with αDdCBEs as an effective approach to optimize base editing outcomes at a single target site. Overall, αDdCBEs enable efficient, specific, and unconstrained mitochondrial base editing.

DddA Homolog Search and Engineering Expand Sequence Compatibility of Mitochondrial Base Editing

Engineering RsDddA as mitochondrial base editor with wide target compatibility and enhanced activity

Developing Mitochondrial Base Editors with Diverse Context Compatibility and High Fidelity Via Saturated Spacer Library

A DddA ortholog-based and transactivator-assisted nuclear and mitochondrial cytosine base editors with expanded target compatibility

Precision mitochondrial DNA editing with high-fidelity DddA-derived base editors

Engineered mitochondrial A-to-G editors with enhanced efficiency and targeting scope

Unconstrained Precision Mitochondrial Genome Editing with αDdCBEs

Harnessing accurate mitochondrial DNA base editing mediated by DdCBEs in a predictable manner

Mitochondrial DNA editing in mice with DddA-TALE fusion deaminases

Mitochondrial base editor induces substantial nuclear off-target mutations

A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing

Improving adenine and dual base editors through introduction of TadA-8e and Rad51DBD

Engineering TadA ortholog-derived cytosine base editor without motif preference and adenosine activity limitation

Expanding C–T base editing toolkit with diversified cytidine deaminases

Streamlined process for effective and strand-selective mitochondrial base editing using mitoBEs

Expanding DdCBE-mediated targeting scope to aC motif preference in rat

In vivo mitochondrial base editing via adeno-associated viral delivery to mouse post-mitotic tissue

Strand-selective base editing of human mitochondrial DNA using mitoBEs

Engineering of cytosine base editors with DNA damage minimization and editing scope diversification

Base editing of organellar DNA with programmable deaminases

Engineering APOBEC3A deaminase for highly accurate and efficient base editing